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Abstract
Background: Early infant HIV diagnosis is challenging in sub-Saharan Africa, particularly in rural areas where laboratory
capacity is limited. Specimens must be transported to central laboratories for testing, leading to delays in diagnosis and
initiation of antiretroviral therapy. This study was undertaken in rural Zambia to measure the turnaround time for
confirmation of HIV infection and identify delays in diagnosis.
Methods: Chart reviews were conducted from 2010–2012 for children undergoing early infant HIV diagnosis at Macha
Hospital in Zambia. Relevant dates, receipt of drugs by mother and child for the prevention of mother-to-child transmission
(PMTCT), and test results were abstracted.
Results: 403 infants provided 476 samples for early infant diagnosis. The median age at the ‘‘6-week’’ and ‘‘6-month’’
assessments was 8.1 weeks and 7.0 months, respectively. The majority of mothers (80%) and infants (67%) received PMTCT.
The median time between sample collection and arrival at the central laboratory in Lusaka was 17 days (IQR: 10, 28); arrival
at the central laboratory to testing was 6 days (IQR: 5, 11); testing to return of results to the clinic was 29 days (IQR: 17, 36);
arrival of results at the clinic to return of results to the caregiver was 45 days (IQR: 24, 79). The total median time from
sample collection to return of results to the caregiver was 92 days (IQR: 84, 145). The proportion of HIV PCR positive samples
was 12%. The total median turnaround time was shorter for HIV PCR positive as compared to negative or invalid samples (85
vs. 92 days; p = 0.08).
Conclusions: Delays in processing and communicating test results were identified, particularly in returning results from the
central laboratory to the clinic and from the clinic to the caregiver. A more efficient process is needed so that caregivers can
be provided test results more rapidly, potentially resulting in earlier treatment initiation and better outcomes for HIV-
infected infants.
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Introduction
Over 90% of the world’s 3.3 million HIV-infected children
reside in sub-Saharan Africa where resources for providing care
and treatment are most limited [1]. Over the past decade, the
capacity for providing antiretroviral treatment (ART) to HIV-
infected individuals increased dramatically, with an estimated
387,500 children in sub-Saharan Africa receiving treatment at the
end of 2010 [2]. While much progress has been made, this
represents only 21% of children living with HIV in need of
antiretroviral therapy, considerably lower than the estimated
coverage of 55% among adults living with HIV [2].
One of the main factors for low coverage of ART among
children is the large number of infants who remain undiagnosed
but would be eligible for treatment under current treatment
guidelines [3]. Diagnosis of HIV infection in early infancy is
challenging in sub-Saharan Africa, as assays based on HIV DNA
or RNA detection must be used rather than the serologic assays
used in older children and adults [4]. These assays require a higher
level of technology, training and cost than is available in many
clinics and district laboratories. A high level of quality assurance
also must be maintained as contamination with even a small
amount of HIV nucleic acid can result in false positive results.
Consequently, testing facilities are primarily available in major
urban areas in centralized laboratories [5]. As a result of these
challenges, only 15% of infants born to HIV-infected women in
2009 were estimated to have received early infant testing [6].
For HIV clinics in rural areas, where many HIV-exposed and
infected infants reside, a centralized testing system poses significant
challenges. Specimens must be transported to central laboratories
and test results transported back to the clinic. Clinic appointments
to provide results to caregivers need to be scheduled to account for
the variability in the timing of this process, leading to delays in
diagnosis and treatment. The World Health Organization (WHO)
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recommends that results be returned to caregivers within four
weeks of specimen collection [3]. Data are emerging, however,
that this process takes longer in rural areas of sub-Saharan Africa
[7–10]. In a program in northern Tanzania with a regional
laboratory serving four health facilities, the median turnaround
time from blood draw to return of results to the caregiver was 5
weeks for HIV-infected infants and 10 weeks for uninfected infants
[7].
To expedite early infant diagnosis and facilitate early linkage to
care and treatment for HIV-infected infants, it is important to
identify where delays in diagnosis occur. This requires that the
duration of each step be documented, from blood draw to arrival
and testing at the central laboratory to return of results to the clinic
and then to the caregiver. Information on each step, however, is
not routinely collected and available at all clinics [5]. This study
was undertaken to measure the turnaround time for early infant
diagnosis in a clinic in rural southern Zambia.
Materials and Methods
Ethics Statement
The study was approved by the Ministry of Health of the
Government of Zambia, the Institutional Review Board of Macha
Research Trust and the Institutional Review Board of the Johns
Hopkins Bloomberg School of Public Health. As the study was
conducted retrospectively, informed consent was not obtained
from participants; however, all data were anonymized prior to
analysis.
Study Population and Setting
This study was conducted at the HIV clinic at Macha Hospital
in rural Southern Province, Zambia. Macha Hospital is located in
Choma District approximately 80 kilometers from the nearest
town of Choma and 350 kilometers from Lusaka by road. The
catchment area of Macha Hospital is populated by traditional
villagers living in small, scattered homesteads. Macha Hospital is
administered by Brethren in Christ Church but functions within
the healthcare system of the Ministry of Health. The hospital
serves as a district-level referral hospital for rural health centers
within an 80 kilometer radius, serving a population of over
150,000 persons. Since 2005, Macha Hospital has provided
programs for the prevention of maternal-to-child HIV transmis-
sion (PMTCT) and for the care and treatment of HIV-infected
individuals [11–13]. HIV-infected pregnant women [14] and
children [3] receive care and treatment according to Ministry of
Health and WHO guidelines.
Early Infant Diagnosis in Zambia and at Macha Hospital
In 2008, the Zambian Ministry of Health issued new guidelines
recommending initiation of ART for all infants younger than 12
months of age and established three national laboratories qualified
to perform early infant diagnosis [15]. Two laboratories were
established in the capital city of Lusaka at the University Teaching
Hospital and Kalingalinga Clinic, and one in Ndola at Arthur
Davison Hospital. HIV-exposed infants were recommended to be
tested by HIV PCR at 6 weeks and, since 2010, at 6 months of
age. If negative at both time points, HIV antibody testing was
recommended at 12 and 18 months of age or 6 weeks after
cessation of breastfeeding [16].
The early infant diagnosis program at Macha Hospital began in
2008 and is administered through the HIV clinic. HIV-infected
women and their exposed infants receive HIV counseling from
clinic staff and are advised to have infants tested by HIV PCR at 6
weeks and 6 months of age. Blood is collected from infants by heel
stick and stored as dried blood spots (DBS) in the laboratory at the
HIV clinic. Batches of specimens are transported to Lusaka in a
hospital vehicle for testing by polymerase chain reaction (PCR) at
the University Teaching Hospital. Efforts are made to transport
specimens once every month. Test results are transported back to
the clinic by the hospital vehicle, logged as returned and stored in
a binder in the laboratory at the HIV clinic. As this process can be
lengthy, caregivers are advised to return to the clinic three months
after specimen collection for the test results. For infants who are
HIV PCR positive, attempts are made by clinic staff to trace the
caregivers in their homes and request that they bring the child
back to the clinic as soon as possible. When caregivers return for
their appointment, clinic staff review the binder to check if the
results were returned. If the results are not found, caregivers are
requested to confirm with the laboratory that results are not
available and are advised to return in another three months. A
shorter interval may be scheduled if the child is due for their 6-
month test, the child did not receive an appropriate PMTCT
regimen, or if the child has clinical evidence of HIV infection. If
the results are available and the infant is HIV PCR negative or the
test was invalid, the testing procedures are repeated at 6 months of
age. If the HIV PCR test is negative or invalid at 6 months of age,
the infant is recommended to return at 12 and 18 months of age or
6 weeks after cessation of breastfeeding (breastfeeding is universal
in this community and children are weaned at a median age of 18
months [unpublished data]) for an HIV antibody test. If the results
are available and the infant is HIV PCR positive, the caregiver is
counseled to have their child begin ART and another DBS
specimen is collected for confirmatory testing.
Study Procedures and Analysis
To assess the turnaround time for early infant testing, a chart
review was conducted at the Macha HIV clinic. All DBS
specimens collected between August 2010 and March 2012 were
abstracted from the laboratory log book. Information routinely
collected from the laboratory log book included clinic number,
sex, date of birth, date of specimen collection, date of specimen
arrival at the laboratory in Lusaka, and date of testing. For study
purposes, clinic staff were requested to record the date test results
were returned to the HIV clinic in the log book.
For infants who had DBS specimens collected, medical charts
were reviewed to confirm the infant’s sex and date of birth, to
collect information on maternal and infant receipt of drugs for
PMTCT, and to document the date results were returned to the
caregiver. When test results were not recorded in the chart to
indicate they were provided to the caregiver, the date of the next
clinic appointment after results were returned to the HIV clinic
was recorded (used for 13% of dates). For infants whose test results
were returned to the caregiver more than 4 months after
collection, reasons for potential delays were evaluated. Four
months was selected as the threshold due to the three-month
interval between scheduled appointments. For infants with a
positive test result, the date of ART initiation was recorded.
Medical charts were reviewed until November 2012 when data
collection was stopped.
Data were entered in duplicate using EpiInfo (Centers for
Disease Control and Prevention) and analyses were conducted in
SAS for Windows version 9.3 (SAS Institute Inc., Cary, NC).
Median turnaround times were calculated for the overall process
(from blood draw to return of results to the caregiver) and for each
step of the process. Median turnaround times for HIV PCR
positive and negative test results were compared using the
Wilcoxon rank sum test.
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Results
Between August 1, 2010 and March 1, 2012, 501 DBS
specimens were collected and sent for testing. Medical records
were found for 476 (95%) corresponding specimens and were
included in the analysis (Figure 1). The 476 specimens were
collected from 403 infants. During the study period, 381 infants
had a scheduled ‘‘6-week’’ test or were tested at the clinic for the
first time at an older age. The median age of infants at the ‘‘6-
week’’ or first test during the study period (n= 381) was 8.1 weeks
(interquartile range [IQR]: 6.4, 18.4) (Table 1). Sixty-three of
these children also had a ‘‘6-month’’ test and ten had a
confirmatory test during the study period. Seven additional infants
had a confirmatory test during the study period following a
positive test prior to the study period, and 15 infants had a ‘‘6-
month’’ test following a ‘‘6-week’’ negative test prior to the study
period. The median age of infants at the ‘‘6-month’’ test (n = 78)
was 7.0 months (IQR: 6.4, 7.8) and 8.8 months (IQR: 7.0, 12.7) at
the confirmatory test (n = 17). The majority of mothers (80%) and
children (67%) received PMTCT. Eighteen percent of children
received no PMTCT and were born to mothers who had also not
received any PMTCT during pregnancy or at birth.
Test results were available for 465 (98%) of the 476 specimens:
58 (12%) were HIV PCR positive, 386 (83%) were HIV PCR
negative and 21 (5%) were invalid (Table 2). Test results were
available for 373 of the 381 infants who underwent their first HIV
testing during the study period, with a similar distribution across
positive and negative results (Table 2). Seventy-three infants were
tested a second time during the study period. Of the 42 infants
with an initial positive result, ten had confirmatory testing during
the study period and eight (80%) were confirmed HIV PCR
positive (two were HIV PCR negative). Of the 313 infants with an
initial negative result, 54 had ‘‘6-month’’ or second tests during the
study period and 49 (91%) remained HIV PCR negative (one was
HIV PCR positive).
Among the 403 infants tested during the study period, test
results differed significantly by maternal receipt of PMTCT.
Among infants born to mothers who received highly active ART
of any duration during pregnancy (n= 205), four (2%) were PCR
positive compared to 14 (13%) among infants born to mothers
who received short course ART (n= 106) or single-dose nevirapine
(n = 5) and 30 (37%) among infants born to mothers who did not
receive PMTCT (n= 81) (p =,0.0001). Among the 42 infants
who were PCR positive at the ‘‘6-week’’ visit during the study
period, 28 (67%) initiated ART by the end of data collection (38%
initiated ART on the day results were given; the remainder
initiated ART within 10–96 days). Among the 14 infants who did
not initiate ART, only two were still in care (3 died, 2 transferred
to another clinic, and 7 defaulted) and were diagnosed shortly
before the end of data collection.
Turnaround time for each step of the process was measured for
each of the 476 specimens (Figure 1). The median time from blood
draw to arrival at the central laboratory was 17 days (IQR: 10, 28).
For the 468 specimens tested, the median time from arrival at the
central laboratory to testing was 6 days (IQR: 5, 11). The median
time from testing at the central laboratory to return of the results
to the Macha HIV clinic (n = 462; six results were missing a date of
return to the clinic) was 29 days (IQR: 17, 36).
Four hundred and thirteen results were returned to the
caregiver (87%), with a median time from arrival of the results
to the Macha HIV clinic to return of the results to the caregiver
(n = 407; six results were missing a date of return to the clinic) of
45 days (IQR: 24, 79). Among the 55 results not returned, reasons
included the caregiver defaulting (n = 27; 49%), infant death
(n = 4; 7% [2 PCR positive and 2 PCR negative results]), transfer
to another clinic (n = 2; 4%), results lost at the clinic (n = 4; 7%),
results misplaced and not found prior to discharge from the clinic
(n = 2; 4%), and results not yet reported to the caregiver by the end
of data collection (n= 16; 29%; median time between arrival of
results at clinic and end of data collection: 10.5 months [IQR: 8.8,
13.4]).
For the entire process, the median time from blood draw to
arrival of the results at the clinic was 54 days (IQR: 38, 73;
Figure 1. Median turnaround time (IQR; range) in days for early infant diagnosis in rural Zambia, 2010–2012. aThese infants were first
tested before the study began; bEight samples were lost at the laboratory; cSix results were missing date of return.
doi:10.1371/journal.pone.0087028.g001
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n=462) and to return the results to the caregiver was 92 days
(IQR: 84, 145; n = 413). Turnaround times from blood draw to
return of results to the caregiver were shorter for specimens that
were PCR positive compared to PCR negative or invalid
specimens (PCR positive: 85 days [IQR: 70, 113; range: 28–
343]; PCR negative or invalid: 92 days [IQR: 84, 146; range: 41–
487]), although this result was not statistically significant (p = 0.08).
This shorter turnaround time was primarily due to a shorter time
between return of results to the clinic and return of results to the
caregiver (PCR positive: 30 days [IQR: 15, 55; range: 1–271];
PCR negative: 46 days [IQR: 27, 83; range: 0–394]; p = 0.003).
Among the 413 specimens for which results were returned to the
caregiver, 167 (40%) had turnaround times greater than 4 months
and 121 (72%) were evaluated for potential delays. Reasons for
delay included results not yet returned at the time of the scheduled
clinic visit or scheduling of clinic appointments at intervals other
than the standard three months (n = 40; 33%), missed appoint-
ments by caregivers (n = 19; 16%), clinic error (results not found by
clinic staff despite being logged as returned to the HIV clinic;
n = 60; 50%), and a combination of missed appointments by the
caregiver and clinic error (n = 2; 2%).
Discussion
In this study of turnaround times for early infant HIV diagnosis
test results in a rural clinic in southern Zambia, the median time
from sample collection to return of the results to the caregiver was
92 days. Significant delays occurred in getting results back to the
clinic from the laboratory and in getting the results to the
caregiver. These findings suggest that reductions in turnaround
time can be achieved by developing strategies to improve
communication between the laboratory and the clinic, and
between the clinic and caregiver.
Similar to other rural settings, the clinic at Macha Hospital
transported samples to a central laboratory in Lusaka approxi-
mately once a month and retrieved results from the laboratory
when the results and transportation were available. As the
duration of this process was variable, healthcare providers
scheduled clinic visits at three-month intervals to avoid having
caregivers travel to the clinic before test results were available. The
three-month interval also coincided with clinic visits for caregivers
to minimize the travel burden [13]. The turnaround time from
sample collection to return of results to the clinic of 54 days
indicates that the three-month interval is justified and is similar to
findings from other studies in Zambia (44.2 days) [8] and Uganda
(35–57 days) [10].
The longest interval for the testing process was from testing at
the central laboratory to return of the results to the clinic. This
interval was approximately one month, suggesting significant
delays and a potential step that could be shortened. In a pilot study
in Zambia, use of an SMS-based system that enabled central
laboratories to report results to clinics in advance of receiving the
hard copy succeeded in reducing the turnaround time from 44.2 to
26.7 days [8]. Using a similar SMS-based system in Uganda, 8 of
10 pilot sites reduced the turnaround time to below the target of 30
days, with SMS results reaching the clinics 17 to 27 days prior to
the hard copy [10]. Similar results were found in Kenya and
Nigeria [9]. Following the pilot study, the Government of Zambia
began implementing the SMS-based message system in rural
districts with national scale-up planned by 2014 [8,17]. In January
2013, an SMS-based system was established at the Macha HIV
clinic and is expected to decrease the time to return test results
from the central laboratory in Lusaka.
Once the results were received at the clinic, a median of 45 days
passed to return the results to the caregiver, for a total turnaround
time of 92 days. Few other studies have documented the duration
of the entire process for comparison. A study in neighboring rural
Table 1. Characteristics of HIV-exposed infants receiving early infant diagnostic testing in rural southern Zambia, 2010–2012.
Total N N (%)
Total HIV-exposed infants 403
Median age (IQR) in weeks at 6 week (or first ever) test during study period 381 8.1 (6.4, 18.4)
Median age (IQR) in months at 6 month test during study period 78 7.0 (6.4, 7.8)
Median age (IQR) in months at confirmatory test during study period 17 8.8 (7.0, 12.7)
Male 402 212 (53%)
Mother received PMTCT 402 321 (80%)
Highly active ARTa 205 (64%)
Short course ART 106 (33%)
Single dose NVP 5 (2%)
Missing information 5 (2%)
Infant received PMTCT 390 269 (67%)
Single dose NVP only 14 (5%)
Single dose NVP plus AZT (7 or 28 days)b 80 (29%)
AZT (7 or 28 days)b only 22 (8%)
NVP (6 weeks or through breastfeeding)b 137 (51%)
AZT (7 or 28 days) plus NVP (6 weeks or through breastfeeding)b 8 (3%)
Missing information 8 (3%)
ART: antiretroviral therapy; AZT: zidovudine; IQR: interquartile range; NVP: nevirapine; PMTCT: prevention of mother-to-child transmission;
aThe timing of the start of highly active ART during pregnancy was variable.
bReported duration of AZT and NVP was variable.
doi:10.1371/journal.pone.0087028.t001
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districts in Zambia measured a total turnaround time of 66.8 days
[8], and a study in rural Tanzania found a total turnaround time
of 5 weeks for HIV-infected infants and 10 weeks for HIV-
uninfected infants [7]. In the current study, efforts were made to
trace caregivers of infants with positive test results to return to the
clinic earlier than scheduled, resulting in a shorter time to return
results to the caregiver (30 days) and a shorter total turnaround
time (85 days) for HIV PCR positive children.
Forty percent of results returned to the caregiver took longer
than four months. Some delays were due to errors on the part of
the caregiver in missing clinic appointments but the majority of
delays were due to errors on the part of the clinic in misplacing or
failing to locate results when caregivers returned for their
appointments. The operational tasks of early infant diagnosis
have increased the burden on an already busy and understaffed
clinic [18]. Without staff dedicated to early infant diagnosis, delays
will likely continue to occur.
Attrition in PMTCT and HIV care programs presents an
additional challenge to diagnosing HIV-infected infants and
enrolling them in care [19,20]. Even after testing HIV-exposed
infants, a significant proportion of caregivers do not return for the
results. At PMTCT clinics in Tanzania and Malawi, only 55%
and 60% of caregivers returned for test results, respectively [7,21].
Importantly, more caregivers of infants testing positive returned,
thereby increasing the likelihood that HIV-infected infants would
enroll in care and receive treatment. In Malawi, 58% of infants
who tested positive started ART [21] and in a report of Namibia’s
national program this proportion reached 70% in 2008 [5]. In the
current study conducted at a single HIV clinic, attrition was low:
86% of caregivers returned for results and 67% of infants who
tested positive started ART by the end of the study.
In addition to decreasing the time to return results to the clinic,
an SMS-based system has the potential to decrease the time to
return results to the caregiver and increase retention [8].
Caregivers with access to mobile phones could be notified that
results are available at the clinic and community health workers
could be notified to contact caregivers without access to mobile
phones. Direct communication with caregivers about the avail-
ability of results could get them to return to the clinic earlier than
scheduled, ensure that results are provided at clinic visits, and
potentially decrease the likelihood of defaulting.
Conclusions
Delays in early infant diagnosis were identified in returning
results from the central laboratory to the clinic and from the clinic
to the caregiver. In this rural setting in sub-Saharan Africa,
transportation presents a challenge for both clinics and caregivers.
For the clinic, the need to transport samples to and results from the
central laboratory creates delays, particularly in determining the
availability of results at the clinic to communicate to the caregiver.
For the caregiver, long travel times to the clinic necessitate
scheduling appointments at three-month intervals to coincide with
their own clinic visits. More efficient communication is needed so
caregivers can be provided test results sooner, potentially resulting
in earlier treatment initiation and better outcomes for HIV-
infected infants.
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